We Use Advanced Techniques For Treatment Of Reduced Mouth Opening
Best Treatment for mouth opening problem due to tobacco and betel nut chewing

Oral sub-mucous fibrosis is a chronic debilitating disease of the oral cavity characterized by inflammation and progressive fibrosis of the submucosal tissues (lamina propria and deeper connective tissues). Oral sub-mucous fibrosis results in marked rigidity and an eventual inability to open the mouth.
Stomatitis includes erythematous mucosa, vesicles, mucosal ulcers, melanotic mucosal pigmentation, and mucosal petechia.
Fibrosis occurs in ruptured vesicles and ulcers when they heal, which is the hallmark of this stage. Early lesions demonstrate blanching of the oral mucosa.
Older lesions include vertical and circular palpable fibrous bands in the buccal mucosa and around the mouth opening or lips, resulting in a mottled, marblelike appearance of the mucosa because of the vertical, thick, fibrous bands running in a blanching mucosa. Specific findings include the following:
Leukoplakia is precancerous and is found in more than 25% of individuals with oral sub-mucous fibrosis.
Speech and hearing deficits may occur because of involvement of the tongue and the eustachian tubes.
Oral dysplasias and squamous cell carcinomas are complications of oral sub-mucous fibrosis. In patients with oral sub-mucous fibrosis, the risk of developing oral carcinoma is 7.6% over a 10-year period.
If the palatal and paratubal muscles are involved in patients with oral sub-mucous fibrosis, conductive hearing loss may occur because of functional stenosis of the eustachian tube.
Patients with oral sub-mucous fibrosis who require anesthesia for trismus correction, resection, and reconstructive (oncoplastic) surgery may have difficulty during laryngoscopy and intubation of the trachea.
The treatment of patients with oral sub-mucous fibrosis depends on the degree of clinical involvement. If the disease is detected at a very early stage, cessation of the habit is sufficient. Most patients with oral sub-mucous fibrosis present with moderate-to-severe disease. Moderate-to-severe oral sub-mucous fibrosis is irreversible. Medical treatment is symptomatic and predominantly aimed at improving mouth movements.
In patients with moderate oral sub-mucous fibrosis, weekly submucosal intralesional injections or topical application of steroids may help prevent further damage.
Lycopene is considered best antioxidant for the treatment of oral sub-mucous fibrosis.
Surgical treatment is indicated in patients with severe trismus and/or biopsy results revealing dysplastic or neoplastic changes. Surgical modalities that have been used include the following:
Excision can result in contracture of the tissue and exacerbation of the condition.
Trismus associated with oral sub-mucous fibrosis may be due to changes in the temporalis tendon secondary to oral sub-mucous fibrosis; therefore, skin grafts may relieve symptoms.
Surgery to create flaps is performed only in patients with oral sub-mucous fibrosis in whom the tongue is not involved.
Use of a laser release procedure was found to increase mouth opening range in 9 patients over a 12-month follow-up period in one study.
Perfect Dental® is the best dental clinic in Jamnagar and our team of specialist doctors is highly skilled and experienced best dentists in Jamnagar. We have a highest success rate of 97%.